Aligos Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $70.1M
Liabilities Breakdown FY2024
Total Liabilities: $99.1M
Asset Breakdown
Total Assets: $70.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $37.0M | 52.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.4M | 3.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $30.7M | 43.8% |
Liabilities Breakdown
Total Liabilities: $99.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.6M | 2.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $96.5M | 97.4% |